Department of Neurosciences, University of the Basque Country UPV/EHU, Leioa, E-48940, Spain.
Achucarro Basque Center for Neuroscience, Science Park of the UPV/EHU, Leioa, Spain.
Glia. 2018 Jul;66(7):1417-1431. doi: 10.1002/glia.23314. Epub 2018 Feb 26.
Astroglial type-1 cannabinoid (CB ) receptors are involved in synaptic transmission, plasticity and behavior by interfering with the so-called tripartite synapse formed by pre- and post-synaptic neuronal elements and surrounding astrocyte processes. However, little is known concerning the subcellular distribution of astroglial CB receptors. In particular, brain CB receptors are mostly localized at cells' plasmalemma, but recent evidence indicates their functional presence in mitochondrial membranes. Whether CB receptors are present in astroglial mitochondria has remained unknown. To investigate this issue, we included conditional knock-out mice lacking astroglial CB receptor expression specifically in glial fibrillary acidic protein (GFAP)-containing astrocytes (GFAP-CB -KO mice) and also generated genetic rescue mice to re-express CB receptors exclusively in astrocytes (GFAP-CB -RS). To better identify astroglial structures by immunoelectron microscopy, global CB knock-out (CB -KO) mice and wild-type (CB -WT) littermates were intra-hippocampally injected with an adeno-associated virus expressing humanized renilla green fluorescent protein (hrGFP) under the control of human GFAP promoter to generate GFAPhrGFP-CB -KO and -WT mice, respectively. Furthermore, double immunogold (for CB ) and immunoperoxidase (for GFAP or hrGFP) revealed that CB receptors are present in astroglial mitochondria from different hippocampal regions of CB -WT, GFAP-CB -RS and GFAPhrGFP-CB -WT mice. Only non-specific gold particles were detected in mouse hippocampi lacking CB receptors. Altogether, we demonstrated the existence of a precise molecular architecture of the CB receptor in astrocytes that will have to be taken into account in evaluating the functional activity of cannabinergic signaling at the tripartite synapse.
星形胶质细胞 1 型大麻素 (CB ) 受体通过干扰由前突触和后突触神经元元件以及周围星形胶质细胞突起形成的所谓三突触,参与突触传递、可塑性和行为。然而,关于星形胶质细胞 CB 受体的亚细胞分布知之甚少。特别是,大脑 CB 受体主要位于细胞质膜上,但最近的证据表明它们在线粒体膜上具有功能存在。星形胶质细胞线粒体中是否存在 CB 受体尚不清楚。为了研究这个问题,我们包括了条件敲除小鼠,这些小鼠特异性地在神经胶质纤维酸性蛋白 (GFAP) 阳性星形胶质细胞中缺乏 CB 受体表达 (GFAP-CB -KO 小鼠),并生成了专门在星形胶质细胞中重新表达 CB 受体的遗传挽救小鼠 (GFAP-CB -RS)。为了通过免疫电子显微镜更好地鉴定星形胶质细胞结构,我们将全身性 CB 敲除 (CB -KO) 小鼠和野生型 (CB -WT) 同窝小鼠海马内注射表达人源化 renilla 绿色荧光蛋白 (hrGFP) 的腺相关病毒,该病毒受人类 GFAP 启动子的控制,分别产生 GFAPhrGFP-CB -KO 和 -WT 小鼠。此外,双重免疫金 (用于 CB ) 和免疫过氧化物酶 (用于 GFAP 或 hrGFP) 显示,CB 受体存在于来自不同海马区域的 CB -WT、GFAP-CB -RS 和 GFAPhrGFP-CB -WT 小鼠的星形胶质细胞线粒体中。在缺乏 CB 受体的小鼠海马中仅检测到非特异性金颗粒。总之,我们证明了 CB 受体在星形胶质细胞中存在精确的分子结构,在评估三突触处大麻素信号传递的功能活性时必须考虑到这一点。